Unipro (MOEX:UPRO)
1.469
-0.001 (-0.07%)
At close: Jul 8, 2022
Revance Therapeutics Market Cap
Unipro has a market cap or net worth of 92.62 billion as of August 5, 2025. Its market cap has decreased by -48.98% in one year.
Market Cap
92.62B
Enterprise Value
88.07B
Revenue
129.03B
Ranking
n/a
PE Ratio
3.01
Stock Price
$1.47
Market Cap Chart
Since January 22, 2010, Unipro's market cap has decreased from 110.15B to 92.62B, a decrease of -15.91%. That is a compound annual growth rate of -1.38%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 8, 2022 | 92.62B | -43.76% |
Dec 30, 2021 | 164.68B | -6.41% |
Dec 30, 2020 | 175.97B | 0.40% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 29, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition